ReviewArchives of gynecology and obstetrics2026
The dual face of human chorionic gonadotropin in the CNS: neuroprotection, signaling, and possible pathological effects.
Review in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman chorionic gonadotropin (hCG) is a glycoprotein hormone critical for reproduction, particularly in pregnancy maintenance and fertility treatments. Beyond reproduction, hCG may influence immune regulation, cancer biology, and neurological processes.
objectiveThis review critically examines the current evidence regarding the potential neurological effects of hCG, synthesizing findings from experimental and clinical studies to assess its proposed roles in neuroinflammation, oxidative stress, and blood-brain barrier modulation.
resultDysregulated hCG levels-arising from pregnancy complications, assisted reproductive technologies (ART), or hCG-secreting tumors-have been associated with markers of neurotoxicity, including neuroinflammation, oxidative stress, and altered blood-brain barrier integrity. Evidence remains largely associative, and causal mechanisms linking hCG to neurobiological vulnerability are not yet established. Proposed pathways include modulation of immune cell activity, neurotransmitter signaling, and endothelial function.
conclusionhCG exhibits a dual nature: essential for reproduction and immune adaptation, yet potentially neurotoxic under dysregulated conditions. This review synthesizes mechanistic hypotheses, highlights knowledge gaps, and underscores the need for rigorous longitudinal and experimental studies to clarify hCG's impact on the nervous system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.